EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of the CPER reverse genetics system for genetic engineering of rabies virus

Yukari Itakura iD, Nijiho Kawaguchi, Koshiro Tabata, Gabriel Gonzalez, Kei Konishi, Aiko Ohnuma, Itsuko Furuta, Naoto Ito iD, Shinji Saito, William W Hall, Yasuko Orba, Hirofumi Sawa iD und 1 weitere

Journal of Virology · 2026

DOI: 10.1128/jvi.01872-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Yukari Itakura und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Hokkaido, Japan. Hauptthemen laut MEDLINE: Rabies virus, Reverse Genetics, Genetic Engineering. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reverse genetics (RG) systems are essential tools for basic virological studies and applied studies using engineered recombinant viruses in various research fields. While the circular polymerase extension reaction (CPER) has been widely applied to prepare a full-length infectious complementary DNA (cDNA) of positive-sense RNA viruses, its use for negative-sense RNA viruses (mononegaviruses) remains limited. Here, we report the first CPER-based RG system for rabies virus (RABV), a member of mononegaviruses. Infectious RABV was successfully rescued from cells transfected with helper plasmids and the CPER product, the assembled overlapping DNA fragments encoding the full-length viral genome cDNA and regulatory elements. Using this system, we generated wild-type, point-mutant, reporter-expressing, and chimeric RABVs, all of which retained their expected biological properties. Deep sequencing revealed that CPER-derived viruses occasionally harbor low-frequency mutations undetectable by Sanger sequencing, highlighting PCR-related artifacts as a limitation. In addition, CPER products with a pUC19 backbone could be directly applied for Escherichia coli transformation and cloning of RABV full-genome cDNA plasmids, offering a flexible, ligase-free cloning strategy for conventional RG. Our work establishes CPER as a versatile platform for engineering recombinant RABVs, facilitating rapid generation and genetic manipulation of RABV with potential applications for research on other mononegaviruses. IMPORTANCE Reverse genetics systems allow researchers to generate recombinant viruses with precise genetic modifications, advancing studies of viral replication, pathogenicity, and vaccine development. However, constructing a full-length viral genome expressing plasmids is often time-consuming and technically demanding. To bypass the cloning process, a simple, cloning-free reverse genetics platform based on the circular polymerase extension reaction (CPER) has been applied for positive-sense RNA viruses. In this study, we applied the CPER-based reverse genetics system for rabies virus (RABV), a mononegavirus, enabling rapid and flexible generation of recombinant RABVs, including mutant, reporter-expressing, and chimeric clones. Our approach greatly facilitates genetic engineering of RABV and provides a versatile framework that can be extended to other mononegaviruses, thereby accelerating both basic and applied virology research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rabies virusReverse GeneticsGenetic EngineeringAnimalsGenome, ViralDNA, ComplementaryPlasmidsCloning, MolecularRNA, ViralCell LineVirus ReplicationHumans

Stichwörter der Autor:innen

CPERmononegavirusrabies virusreverse genetics

Substanzen

DNA, ComplementaryRNA, Viral

Autor:innen und Institutionen

  • Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Laboratory for Drug Discovery & Disease Research, Shionogi and Co Ltd, Osaka, Japan.
  • Division of Anti-Virus Drug Research, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Technical Office, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.

ORCID-Profile: Yukari Itakura, Naoto Ito, Hirofumi Sawa, Michihito Sasaki

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Itakura, Y., Kawaguchi, N., Tabata, K., Gonzalez, G., Konishi, K., Ohnuma, A., Furuta, I., Ito, N., Saito, S., Hall, W. W., Orba, Y., Sawa, H., & Sasaki, M. (2026). Application of the CPER reverse genetics system for genetic engineering of rabies virus. Journal of Virology. https://doi.org/10.1128/jvi.01872-25

Vancouver

Itakura Y, Kawaguchi N, Tabata K, Gonzalez G, Konishi K, Ohnuma A, et al. Application of the CPER reverse genetics system for genetic engineering of rabies virus. Journal of Virology. 2026. doi:10.1128/jvi.01872-25

BibTeX
@article{Itakura2026,
  author = {Itakura, Yukari and Kawaguchi, Nijiho and Tabata, Koshiro and Gonzalez, Gabriel and Konishi, Kei and Ohnuma, Aiko and Furuta, Itsuko and Ito, Naoto and Saito, Shinji and Hall, William W and Orba, Yasuko and Sawa, Hirofumi and Sasaki, Michihito},
  title = {Application of the CPER reverse genetics system for genetic engineering of rabies virus},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.01872-25}
}
Kostenlos starten →